SCHEMBL3787098

SCHEMBL3787098

CCC(C)c1cccc(B(O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC4 P56524 1/20 0.53
▸ HDAC2 Q92769 1/20 0.53
▸ HDAC8 Q9BY41 1/20 0.53
▸ LPL P06858 2/20 0.45
▸ LIPG Q9Y5X9 2/20 0.45
▸ ENPP2 Q13822 7/20 0.44
▸ ALDH1A1 P00352 2/20 0.43
▸ USP2 O75604 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ PKM P14618 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.42
▸ MGLL Q99685 2/20 0.41
▸ TSHR P16473 1/20 0.37
▸ CA4 P22748 1/20 0.37
▸ CA6 P23280 1/20 0.37
▸ CA5A P35218 1/20 0.37
▸ CA7 P43166 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16293432 0.85 ENPP2 (0.48) HDAC4HDAC2HDAC8LPLLIPG
SCHEMBL16293433 0.85 ENPP2 (0.48) HDAC4HDAC2HDAC8LPLLIPG
SCHEMBL20129360 0.82 TRPA1 (0.49) LPLLIPGENPP2ALDH1A1KDM4E
SCHEMBL1233772 0.81 LMNA (0.53) LPLLIPGENPP2ALDH1A1GAA
SCHEMBL31430960 0.80 ENPP2 (0.50) HDAC4HDAC2HDAC8LPLLIPG
SCHEMBL129343 0.80 ENPP2 (0.50) HDAC4HDAC2HDAC8LPLLIPG
SCHEMBL2722929 0.80 FFAR1 (0.46) HDAC4HDAC2HDAC8LPLLIPG
SCHEMBL1006801 0.80 HDAC4 (0.62) HDAC4HDAC2HDAC8ALDH1A1USP2
SCHEMBL1812495 0.79 ENPP2 (0.48) LPLLIPGENPP2ALDH1A1KDM4E
SCHEMBL623469 0.76 LPL (0.50) LPLLIPGENPP2ALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9678082-B2 Method of traceless labeling glycoproteins on surface and application thereof NATIONAL SUN YAT-SEN UNIVERSITY (TW) 2017-06-13 — — US disclosed
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2010-04-08 — — US disclosed
EP-1914221-A1 PROCESS FOR PRODUCING BIARYL COMPOUND Sumitomo Chemical Company, Limited (JP) 2008-04-23 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100087680-A1 METHOD FOR PRODUCING BIARYL COMPOUND NISCH, BLVRB, BBOX1 HDAC4 3220/4885HDAC2 549/4885HDAC8 1421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback